Best consultancies

About Incisive Health

Key Specialisms

Brussels Office Since

2016

Firm Description

Incisive Health is an award-winning healthcare policy and communications consultancy. We deliver the results that matter for our clients and – ultimately – for the patients they serve. Our multilingual, multinational team of experts, based in Brussels and in London, knows how to cut through the noise to deliver real change, improving results, enhancing reputation and changing patients’ lives. As specialists in health, we understand the detail but can see the big picture. We know how to change minds, mobilise advocates and deliver results. Our work has changed policy and transformed lives.

Ownership Structure

An Ashfield Health Company, part of UDG Healthcare PLC.

 

International Structure

Incisive Health is part of Ashfield Health, a new healthcare marketing and communications network built for today where a global mindset meets individual depth and specialism. Together with our family of agencies, we create life-changing solutions that achieve new realities for our clients.

Key Strengths

Our services range from market access communications and strategy development through to media campaigns and clinical advocacy, all underpinned by a deep understanding of health policy and politics. Every client’s problem is unique, so the programmes we create are tailored to deliver on their ambitions. Our team’s experience and expertise allow us to focus on the interventions that will make the difference. We have developed a series of methodologies which create the firm foundations for creative strategies, impactful programmes and exceptional results.

Number of Public Affairs Consultants

15 in Brussels and 45 across the Group

Key Clients

Astellas, Biogen, Edwards Lifesciences, European Brain Council (EBC), European Federation of Pharmaceutical Industries and Associations (EFPIA), Global Blood Therapeutics (GBT), Illumina, Jazz Pharmaceuticals, MedTech Europe, MSD, Norgine, Plasma Protein Therapeutics Association (PPTA), Roche, Roche Diagnostics, Stryker, Takeda, Vifor Pharma.

Thought Leadership

At Incisive Health, we pride ourselves on our insights and are not afraid to give our opinion. Our team is passionate about what they do: interrogating the latest policy developments and understanding what they mean for patients. This is underpinned by our values: expert, challenging, exceptional, collaborative and ambitious.

In 2020 we launched a new series of breakfast events: the Incisive Health Morning Club. The Morning Club is a unique opportunity for experts to collaboratively shed light on key EU health policy topics, including those that are less debated in the public sphere and that could be further prioritised by policy makers. With this platform, Incisive Health gives a voice to patients, healthcare professionals, industry representatives, academia and other key stakeholders on topics such as the future of brain health policy in Europe, the revision of the In Vitro Diagnostic Regulation and the need to increase plasma donations across Europe. Feel free to contact us to discuss a topic that you would like to see included in our 2021 Morning Club calendar.

Best in Brussels 2021 Report

Best in Brussels is the first and only independent resource for organisations wanting to identify, compare and choose the best partners in Brussels for their advocacy needs.

Top